{
    "2018-06-13": [
        [
            {
                "time": "",
                "original_text": "股获券商买入评级 华夏幸福目标涨幅达133.87%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "华夏幸福",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "13股昨夜发利好消息 今日待检",
                "features": {
                    "keywords": [
                        "利好消息",
                        "待检"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "四价流感疫苗获批上市 市场规模有望超百亿元",
                "features": {
                    "keywords": [
                        "四价流感疫苗",
                        "获批上市",
                        "市场规模",
                        "百亿元"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "流感疫苗市场规模有望超百亿 机构看好10只概念股",
                "features": {
                    "keywords": [
                        "流感疫苗",
                        "市场规模",
                        "机构看好",
                        "概念股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物制品行业周报:把握业绩主线,精选优质个股",
                "features": {
                    "keywords": [
                        "生物制品",
                        "行业周报",
                        "业绩主线",
                        "优质个股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物事件点评:四价流感疫苗获批生产,有望大幅增厚公司业绩",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "获批生产",
                        "增厚业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物:四价流感疫苗获批 有望增厚业绩",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "获批",
                        "增厚业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}